Engineered zinc oxide nanoparticles; biological interactions at the organ level

Current Medicinal Chemistry

Volumn 23, Issue 35, 2016, Pages 4057-4068

  Sruthi, Sudhakaran ^a   Mohanan, Parayanthala Valappil ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Immune response; Neurotoxicity; Organ toxicity; ROS; ZnO nanoparticle

Indexed keywords

ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; ZINC OXIDE;

BRAIN TOXICITY; CARDIOTOXICITY; HUMAN; IMMUNOTOXICITY; LIVER TOXICITY; LUNG TOXICITY; NANOENGINEERING; NANOTOXICOLOGY; NEPHROTOXICITY; NONHUMAN; REVIEW; SKIN TOXICITY; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECTS; IMMUNE SYSTEM; LIVER; LUNG; METABOLISM; OXIDATIVE STRESS; SKIN;

ANIMALS; BRAIN; HUMANS; IMMUNE SYSTEM; LIVER; LUNG; METAL NANOPARTICLES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN; ZINC OXIDE;

EID: 84995902753     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160607224628     Document Type: Review

References (81)

1. Zhang, Y.; Nayak, T.R.; Hong, H.; Cai, W. Biomedical applications of zinc oxide nanomaterials. Curr. Mol. Med., 2013, 13(10), 1633-1645.
2. Degen, A.; Kosec, M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J. Eur. Ceramic Soc., 2000, 20, 667-673.
3. Smita, S.; Gupta, S.K.; Bartonova, A.; Dusinska, M.; Gutleb, A.C.; Rahman, Q. Nanoparticles in the environment: assessment using the causal diagram approach. Environ. Health, 2012, 11(Suppl. 1), S13.
4. Wiechers, J.W.; Musee, N. Engineered inorganic nanoparticles and cosmetics: facts, issues, knowledge gaps and challenges. J. Biomed. Nanotechnol., 2010, 6(5), 408-431.
5. Pandurangan, M.; Kim, D.H. In vitro toxicity of zinc oxide nanoparticles: a review. J. Nanopart. Res., 2015, 17, 1-8.
6. Smijs, T.G.; Pavel, S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness. Nanotechnol. Sci. Appl., 2011, 4, 95-112.
7. Nohynek, G.J.; Dufour, E.K.; Roberts, M.S. Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol. Physiol., 2008, 21(3), 136-149.
8. Jung, E.C.; Maibach, H.I. Animal Models for Percutaneous Absorption. J. Appl. Toxicol., 2015, 35(1), 1-10.
9. Gulson, B.; McCall, M.; Korsch, M.; Gomez, L.; Casey, P.; Oytam, Y.; Taylor, A.; McCulloch, M.; Trotter, J.; Kinsley, L.; Greenoak, G. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol. Sci., 2010, 118(1), 140-149.
10. Zvyagin, A.V.; Zhao, X.; Gierden, A.; Sanchez, W.; Ross, J.A.; Roberts, M.S. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J. Biomed. Opt., 2008, 13(6), 064031.
11. Nohynek, G.J.; Lademann, J.; Ribaud, C.; Roberts, M.S. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol., 2007, 37(3), 251-277.
12. Lademann, J.; Otberg, N.; Jacobi, U.; Hoffman, R.M.; Blume-Peytavi, U. Follicular penetration and targeting. J. Investig. Dermatol. Symp. Proc., 2005, 10(3), 301-303.
13. Rostan, E.F.; De Buys, H.V.; Madey, D.L.; Pinnell, S.R. Evidence supporting zinc as an important antioxidant for skin. Int. J. Dermatol., 2002, 41(9), 606-611.
14. Osmond, M J; Mccall, MJ. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology, 2010, 4(1), 15-41.
15. Jang, Y.S.; Lee, E.Y.; Park, Y.H. The potential for skin irritation, phototoxicity, and sensitization of ZnO nanoparticles. Mol. Cell. Toxicol., 2012, 8, 171-177.
16. Mortensen, L.J.; Oberdörster, G.; Pentland, A.P.; Delouise, L.A. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett., 2008, 8(9), 2779-2787.
17. Meyer, K.; Rajanahalli, P.; Ahamed, M.; Rowe, J.J.; Hong, Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol. In Vitro, 2011, 25(8), 1721-1726.
18. Sharma, V.; Shukla, R.K.; Saxena, N.; Parmar, D.; Das, M.; Dhawan, A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett., 2009, 185(3), 211-218.
19. Leite-Silva, V.R.; Mandelli de Almeida, M.; Fradin, A. Delivery of drugs applied topically to the skin. Expert. Rev. Dermatol., 2012, 7, 383-397.
20. Giusti, F.; Martella, A.; Bertoni, L.; Seidenari, S. Skin barrier, hydration, and pH of the skin of infants under 2 years of age. Pediatr. Dermatol., 2001, 18(2), 93-96.
21. Muizzuddin, N.; Marenus, K.D.; Schnittger, S.F.; Sullivan, M.; Maes, D.H. Effect of systemic hormonal cyclicity on skin. J. Cosmet. Sci., 2005, 56(5), 311-321.
22. Swift, D.L.; Montassier, N.; Hopke, P.K. Inspiratory deposition of ultrafine particles in human nasal replicate cast. J. Aerosol Sci., 1992, 23, 65-72.
23. ICRP. Human respiratory tract model for radiological protection. Ann. ICRP, 1994, 24(1-3), 1-482.
24. Cheng, Y.S.; Yeh, H.C.; Guilmette, R.A. Nasal deposition of ultrafine particles in human volunteers and its relationship to airway geometry. Aerosol Sci. Technol., 1996, 25, 274-291.
25. Cho, W.S.; Duffin, R.; Howie, S.E.; Scotton, C.J.; Wallace, W.A.; Macnee, W.; Bradley, M.; Megson, I.L.; Donaldson, K. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part. Fibre Toxicol., 2011, 8, 27.
26. Xia, T.; Zhao, Y.; Sager, T.; George, S.; Pokhrel, S.; Li, N.; Schoenfeld, D.; Meng, H.; Lin, S.; Wang, X.; Wang, M.; Ji, Z.; Zink, J.I.; Mädler, L.; Castranova, V.; Lin, S.; Nel, A.E. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano, 2011, 5(2), 1223-1235.
27. Jachak, A.; Lai, S.K.; Hida, K.; Suk, J.S.; Markovic, N.; Biswal, S.; Breysse, P.N.; Hanes, J. Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology, 2012, 6(6), 614-622.
28. Lam, H.F.; Conner, M.W.; Rogers, A.E.; Fitzgerald, S.; Amdur, M.O. Functional and morphologic changes in the lungs of Guinea Pigs exposed to freshly generated ultrafine zinc oxide. Toxicol. Appl. Pharmacol., 1985, 78(1), 29-38.
29. Fine, J.M.; Gordon, T.; Chen, L.C.; Kinney, P.; Falcone, G.; Beckett, W.S. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. J. Occup. Environ. Med., 1997, 39(8), 722-726.
30. Fine, J.M.; Gordon, T.; Chen, L.C.; Kinney, P.; Falcone, G.; Sparer, J.; Beckett, W.S. Characterization of clinical tolerance to inhaled zinc oxide in naive subjects and sheet metal workers. J. Occup. Environ. Med., 2000, 42(11), 1085-1091.
31. Wesselkamper, S.C.; Chen, L.C.; Gordon, T. Development of pulmonary tolerance in mice exposed to zinc oxide fumes. Toxicol. Sci., 2001, 60(1), 144-151.
32. Vandebriel, R.J.; De Jong, W.H. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol. Sci. Appl., 2012, 5, 61-71.
33. Domingos, RF Agglomeration and dissolution of zinc oxide nanoparticles: role of pH, ionic strength and fulvic acid. Environ. Chem., 2013, 10, 306-312.
34. Warheit, D.B.; Sayes, C.M.; Reed, K.L. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ. Sci. Technol., 2009, 43(20), 7939-7945.
35. Sharma, V.; Anderson, D.; Dhawan, A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis, 2012, 17(8), 852-870.
36. Sharma, V.; Anderson, D.; Dhawan, A. Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J. Biomed. Nanotechnol., 2011, 7(1), 98-99.
37. Sharma, V.; Singh, P.; Pandey, A.K.; Dhawan, A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat. Res., 2012, 745(1-2), 84-91.
38. Pasupuleti, S.; Alapati, S.; Ganapathy, S.; Anumolu, G.; Pully, N.R.; Prakhya, B.M. Toxicity of zinc oxide nanoparticles through oral route. Toxicol. Ind. Health, 2012, 28(8), 675-686.
39. Li, C.H.; Shen, C.C.; Cheng, Y.W.; Huang, S.H.; Wu, C.C.; Kao, C.C.; Liao, J.W.; Kang, J.J. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology, 2012, 6(7), 746-756.
40. Hong, T.K.; Tripathy, N.; Son, H.J. A comprehensive in vitro and in vivo study of ZnO nanoparticles toxicity. J. Mater. Chem. B Mater. Biol. Med., 2013, 1, 2985-2992.
41. Choi, J.; Kim, H.; Kim, P.; Jo, E.; Kim, H.M.; Lee, M.Y.; Jin, S.M.; Park, K. Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration. J. Toxicol. Environ. Health A, 2015, 78(4), 226-243.
42. Konduru, N.V.; Murdaugh, K.M.; Swami, A. Surface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulation. Nanotoxicol, 2015, pp. 1-8.
43. Deng, X.; Luan, Q.; Chen, W.; Wang, Y.; Wu, M.; Zhang, H.; Jiao, Z. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology, 2009, 20(11), 115101.
44. Jeng, HA; Swanson, J Toxicity of metal oxide nanoparticles in mammalian cells. J. Environ. Sci. Health A Tox Hazard Subst. Environ. Eng., 2006, 41(699), 711.
45. Zhao, J.; Xu, L.; Zhang, T.; Ren, G.; Yang, Z. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology, 2009, 30(2), 220-230.
46. Wang, J.; Deng, X.; Zhang, F.; Chen, D.; Ding, W. ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res. Lett., 2014, 9(1), 117.
47. Sruthi, S.; Mohanan, P.V. Investigation on cellular interactions of astrocytes with zinc oxide nanoparticles using rat C6 cell lines. Colloids Surf. B Biointerfaces, 2015, 133, 1-11.
48. Kao, Y.Y.; Cheng, T.J.; Yang, D.M.; Wang, C.T.; Chiung, Y.M.; Liu, P.S. Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J. Mol. Neurosci., 2012, 48(2), 464-471.
49. Amara, S.; Ben-Slama, I.; Mrad, I.; Rihane, N.; Jeljeli, M.; El-Mir, L.; Ben-Rhouma, K.; Rachidi, W.; Sève, M.; Abdelmelek, H.; Sakly, M. Acute exposure to zinc oxide nanoparticles does not affect the cognitive capacity and neurotransmitters levels in adult rats. Nanotoxicology, 2014, 8(Suppl. 1), 208-215.
50. Han, D.; Tian, Y.; Zhang, T.; Ren, G.; Yang, Z. Nano-zinc oxide damages spatial cognition capability via overenhanced long-term potentiation in hippocampus of Wistar rats. Int. J. Nanomedicine, 2011, 6, 1453-1461.
51. Xie, Y.; Wang, Y.; Zhang, T. Yang. Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J. Biomed. Sci., 2012, 19, 1-11.
52. Mocchegiani, E.; Bertoni-Freddari, C.; Marcellini, F.; Malavolta, M. Brain, aging and neurodegeneration: role of zinc ion availability. Prog. Neurobiol., 2005, 75(6), 367-390.
53. Guan, R.; Kang, T.; Lu, F.; Zhang, Z.; Shen, H.; Liu, M. Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles. Nanoscale Res. Lett., 2012, 7(1), 602.
54. Pujalté, I; Passagne, I; Brouillaud, B Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part. Fibre Toxicol, 2011, 8.
55. Yan, G.; Huang, Y.; Bu, Q. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J. Environ. Sci. Health. A. Tox. Hazard Subst. Environ. Eng., 2012, 47, 577-588.
56. Faddah, L.M.; Abdel Baky, N.A.; Al-Rasheed, N.M.; Al-Rasheed, N.M.; Fatani, A.J.; Atteya, M. Role of quercetin and arginine in ameliorating nano zinc oxide-induced nephrotoxicity in rats. BMC Complement. Altern. Med., 2012, 12, 60.
57. Amara, S.; Slama, I.B.; Mrad, I.; Rihane, N.; Khemissi, W.; El Mir, L.; Rhouma, K.B.; Abdelmelek, H.; Sakly, M. Effects of zinc oxide nanoparticles and/or zinc chloride on biochemical parameters and mineral levels in rat liver and kidney. Hum. Exp. Toxicol., 2014, 33(11), 1150-1157.
58. ZnO - Study on the toxicity and distribution of nanoscale ZnO in Wistar rats after i.v. administration and observation period of up to 4 weeks. In: Laboratory Project Identification No. 38C0488/06106. Experimental Toxicology and Ecology, BASF SE; Germany: Ludwigshafen, 2009.
59. Wang, B.; Feng, W.; Wang, M. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J. Nanopart. Res., 2008, 10, 263-276.
60. Zheng, Y.; Li, R. In vitro and in vivo biocompatibility studies of ZnO nanoparticles. Int. J. Mod. Phys. B, 2009, 23, 1566-1571.
61. Paszek, E Zinc Oxide Nanoparticles Impair the Integrity of Human Umbilical Vein Endothelial Cell Monolayer In Vitro. J. Biomed. Nanotechnol, 2012, 8(6), 1-11.
62. Tada-Oikawa, S.; Ichihara, G.; Suzuki, Y. Zn(II) released from zinc oxide nano/micro particles suppresses vasculogenesis in human endothelial colony-forming cells. Toxicol. Rep., 2015, 2, 692-701.
63. Gojova, A.; Guo, B.; Kota, R.S.; Rutledge, J.C.; Kennedy, I.M.; Barakat, A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect., 2007, 115(3), 403-409.
64. Tsou, T.C.; Yeh, S.C.; Tsai, F.Y.; Lin, H.J.; Cheng, T.J.; Chao, H.R.; Tai, L.A. Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. J. Hazard. Mater., 2010, 183(1-3), 182-188.
65. Luyts, K.; Smulders, S.; Napierska, D.; Van Kerckhoven, S.; Poels, K.; Scheers, H.; Hemmeryckx, B.; Nemery, B.; Hoylaerts, M.F.; Hoet, P.H. Pulmonary and hemostatic toxicity of multi-walled carbon nanotubes and zinc oxide nanoparticles after pulmonary exposure in Bmal1 knockout mice. Part. Fibre Toxicol., 2014, 11, 61.
66. Li, C.H.; Liao, P.L.; Shyu, M.K.; Liu, C.W.; Kao, C.C.; Huang, S.H.; Cheng, Y.W.; Kang, J.J. Zinc oxide nanoparticles-induced intercellular adhesion molecule 1 expression requires Rac1/Cdc42, mixed lineage kinase 3, and c-Jun Nterminal kinase activation in endothelial cells. Toxicol. Sci., 2012, 126(1), 162-172.
67. Suzuki, Y.; Tada-Oikawa, S.; Ichihara, G.; Yabata, M.; Izuoka, K.; Suzuki, M.; Sakai, K.; Ichihara, S. Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation. Toxicol. Appl. Pharmacol., 2014, 278(1), 16-25.
68. Hanley, C.; Layne, J.; Punnoose, A.; Reddy, K.M.; Coombs, I.; Coombs, A.; Feris, K.; Wingett, D. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology, 2008, 19(29), 295103.
69. Hanley, C.; Thurber, A.; Hanna, C.; Punnoose, A.; Zhang, J.; Wingett, D.G. The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction. Nanoscale Res. Lett., 2009, 4(12), 1409-1420.
70. Ho, M.; Wu, K.Y.; Chein, H.M.; Chen, L.C.; Cheng, T.J. Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhal. Toxicol., 2011, 23(14), 947-956.
71. Song, W.; Zhang, J.; Guo, J.; Zhang, J.; Ding, F.; Li, L.; Sun, Z. Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol. Lett., 2010, 199(3), 389-397.
72. Roy, R.; Parashar, V.; Chauhan, L.K.; Shanker, R.; Das, M.; Tripathi, A.; Dwivedi, P.D. Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling. Toxicol. In Vitro, 2014, 28(3), 457-467.
73. Lucarelli, M.; Gatti, A.M.; Savarino, G.; Quattroni, P.; Martinelli, L.; Monari, E.; Boraschi, D. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur. Cytokine Netw., 2004, metallic particles. Eur. Cytokine Netw., 2004, 15(4), 339-346.
74. Chang, H.; Ho, C.C.; Yang, C.S.; Chang, W.H.; Tsai, M.H.; Tsai, H.T.; Lin, P. Involvement of MyD88 in zinc oxide nanoparticle-induced lung inflammation. Exp. Toxicol. Pathol., 2013, 65(6), 887-896.
75. O'Neill, L.A.; Golenbock, D.; Bowie, A.G. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol., 2013, 13(6), 453-460.
76. Luo, Y.H.; Chang, L.W.; Lin, P. Metal-based nanoparticles and the immune system: activation, inflammation, and potential applications. Bio Med Res. Int., 2015, 2015, 143720.
77. Gill, R.; Tsung, A.; Billiar, T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic. Biol. Med., 2010, 48(9), 1121-1132.
78. Giovanni, M.; Yue, J.; Zhang, L.; Xie, J.; Ong, C.N.; Leong, D.T. Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles. J. Hazard. Mater., 2015, 297, 146-152.
79. Andersson-Willman, B.; Gehrmann, U.; Cansu, Z.; Buerki-Thurnherr, T.; Krug, H.F.; Gabrielsson, S.; Scheynius, A. Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol. Appl. Pharmacol., 2012, 264(1), 94-103.
80. Roy, R.; Das, M.; Dwivedi, P.D. Toxicological mode of action of ZnO nanoparticles: Impact on immune cells. Mol. Immunol., 2015, 63(2), 184-192.
81. Chia, S.L.; Tay, C.Y.; Setyawati, M.I.; Leong, D.T. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles. Small, 2015, 11(6), 702-712.